محدّث
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
الأمراض المعدية 2025قاعدة المعارف الطبية
التوصيات السريرية
اطّلع على التوصيات الرسمية ووثائق التوافق والتحديثات المنشورة من قِبل الجمعيات العلمية والسلطات الصحية.
مصادر رسمية وموثوقةالجمعيات العلمية والسلطات الصحية
معلومات محدّثةرصد علمي مستمر
وصول مجاني للمهنيينفي خدمة المجتمع الطبي
تطبيق ASEM
إرشادات سريرية أينما كنت
استكشف التوصيات الطبية الرسمية والإرشادات السريرية في تطبيق ASEM.
احصل على تطبيق ASEMمنشورات وتحديثات مهمة
عرض المنشورات الحديثة
محدّث
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
أمراض القلب 2025
النشر الرسمي
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
طب الأطفال 2026جميع التوصيات (524 نتائج)
عوامل التصفية
Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]”. NACI recomme...
Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax CO...
Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6...
Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID...
Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]”. NACI i...
Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID...
Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]”. NACI up...
Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron...
Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]”...
Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a...